B&D White Capital Company’s GSK GSK Stock Holding History

B&D White Capital Company’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$257K	Hold	4,900	–	–	0.03%	86
2026 Q1	$270K	Hold	4,900	–	–	0.03%	67
2025 Q4	$240K	Hold	4,900	–	–	0.03%	71
2025 Q3	$211K	Buy	+4,900	New	+$191K	0.03%	74
2022 Q4	–	Sell	-27,530	Closed	-$810K	–	104
2022 Q3	$810K	Buy	+27,530	New	+$1.04M	0.3%	37

Other funds holding GSK

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

MHI

Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

FVWA

Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return

B&D White Capital Company's GSK Position: Q2 2026 in Review

B&D White Capital Company held its GSK (GSK) position steady in Q2 2026 at 4,900 shares worth $257K. The position accounts for 0.03% of the portfolio, ranked #86.

B&D White Capital Company first reported a position in GSK in Q3 2022 and has held it in 5 quarters since. The position peaked at $810K in Q3 2022. 439 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

B&D White Capital Company held 4,900 shares of GSK worth $257K as of Q2 2026.
B&D White Capital Company left its GSK share count unchanged in Q2 2026.
GSK made up 0.03% of B&D White Capital Company's portfolio in Q2 2026, its #86 holding.
B&D White Capital Company first reported a position in GSK in Q3 2022 and has held it in 5 quarters since.
B&D White Capital Company's GSK position peaked at $810K in Q3 2022.
439 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on B&D White Capital Company's 13F filing for Q2 2026, filed 31 Jul 2026.